SCHEMBL6990941

SCHEMBL6990941

OCCCOc1cn(-c2ccccc2)c2ccccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.45
SRC P12931 2/20 0.45
KCNA3 P22001 1/20 0.45
NR4A2 P43354 1/20 0.44
SCN9A Q15858 3/20 0.42
MEN1 O00255 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
PLA2G4A P47712 3/20 0.39
ESRRA P11474 1/20 0.39
METTL3 Q86U44 1/20 0.38
METTL14 Q9HCE5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13335079 0.77 NR4A2 (0.50) NR4A2SCN9AHDAC1HDAC2ESRRA
SCHEMBL14132976 0.75 POLB (0.60) NR4A2SCN9APLA2G4AESRRAPOLB
SCHEMBL28878338 0.74 NR4A2 (0.55) FGFR1SRCNR4A2MEN1MAPT
SCHEMBL1304711 0.71 HTR7 (0.57) NR4A2SCN9APLA2G4AESRRAPOLB
SCHEMBL7431522 0.71 NR4A2 (0.56) NR4A2SCN9AHTTHDAC1HDAC2
SCHEMBL11116979 0.70 NR4A2 (0.55) NR4A2MEN1GAAMAPTKMT2A
SCHEMBL23292980 0.70 NR4A2 (0.39) NR4A2SCN9AMEN1KMT2AHDAC1
SCHEMBL26153471 0.70 MEN1 (0.50) MEN1HTTKMT2AKDM4EPOLB
SCHEMBL19180068 0.69 NR4A2 (0.50) NR4A2SCN9AMEN1CYP2C9KMT2A
SCHEMBL24523010 0.69 KCNA3 (0.76) KCNA3MEN1CYP1A2CYP3A4GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0859004-B1 Piperidine derivatives having anxiolytic effect LUNDBECK & CO AS H (DK) 2003-05-02 EP disclosed
US-6207677-B1 ADMINISERING SIGMA RECEPTOR BINDING PIPERIDINE DERIVATIVE FOR TREATING ANXIETY, EPILEPSY, CONVULSION, MOVEMENT DISORDER, AMNESIA H. LUNDBECK A/S (DK) 2001-03-27 US disclosed
US-6031099-A Piperidine derivates having anxiolytic effect H. LUNDBECK A/S (DK) 2000-02-29 US disclosed
US-5807871-A PSYCHOLOGICAL DISORDERS, ALZHEIMER OR PARKINSON DISEASE H. LUNDBECK A/S (DK) 1998-09-15 US disclosed
EP-0593511-B1 PIPERIDINE DERIVATES HAVING ANXIOLYTIC EFFECT LUNDBECK & CO AS H (DK) 1998-09-02 EP disclosed
EP-0859004-A1 Piperidine derivatives having anxiolytic effect H. LUNDBECK A/S (DK) 1998-08-19 EP disclosed
EP-0853085-A1 Piperidine derivatives having anxiolytic effect H. LUNDBECK A/S (DK) 1998-07-15 EP disclosed
US-5665725-A Piperidine derivatives having anxiolytic effect Lundbeck, H. (DK) 1997-09-09 US disclosed
EP-0593511-A1 PIPERIDINE DERIVATES HAVING ANXIOLYTIC EFFECT H. LUNDBECK A/S (DK) 1994-04-27 EP disclosed
WO-1992022554-A1 PIPERIDINE DERIVATES HAVING ANXIOLYTIC EFFECT H. LUNDBECK A/S (DK) 1992-12-23 WO disclosed
EP-0518805-A1 Piperidine derivatives H. LUNDBECK A/S (DK) 1992-12-16 EP disclosed